New order removes generic company from three separate
federal court antitrust cases; litigation continues against brand drug
View the original article here: US FTC settles ‘reverse-payment’ Teva suit
The article was originally posted on IPMagazine.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.